Category: Spotlight

HIV Vaccine Research A community and civil society perspective, and commentary on HVTN 702

Background: On 3rd February 2020, the US National Institute of Allergy and Infectious Diseases (NIAID) announced that HVTN 702, a large-scale HIV vaccine efficacy trial of a vaccine candidate, has stopped vaccinations because the vaccine does not prevent HIV. The trial, conducted at 14 sites across South Africa, followed more than 5400 HIV-negative 18–35-year-olds over […]

Introducing AfNHi youth cohort – Evelyn Odhiambo

“As a young African leader, I chose HIV research advocacy as my focus because I grew up in a community largely affected and infected with HIV.” One of the greatest needs for prevention advocacy in my home town, Nyanza region, is how to fuse Advocacy and Behavior Change communication. This would target people’s attitudes and […]